These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1821257)

  • 21. Disproportionate loss of noradrenergic and cholinergic neurons as cause of depression in Alzheimer's disease--a hypothesis.
    Förstl H; Levy R; Burns A; Luthert P; Cairns N
    Pharmacopsychiatry; 1994 Jan; 27(1):11-5. PubMed ID: 8159776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease.
    Mann DM; Yates PO; Marcyniuk B
    J Neurol Neurosurg Psychiatry; 1984 Feb; 47(2):201-3. PubMed ID: 6707659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain.
    Strada O; Hirsch EC; Javoy-Agid F; Lehéricy S; Ruberg M; Hauw JJ; Agid Y
    J Neurosci; 1992 Dec; 12(12):4766-74. PubMed ID: 1464766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia.
    Casanova MF; Carosella NW; Gold JM; Kleinman JE; Weinberger DR; Powers RE
    Psychiatry Res; 1993 Oct; 49(1):41-62. PubMed ID: 8140181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plaque-like lesions in the basal forebrain in Alzheimer's disease.
    Jacobs RW; Farivar N; Butcher LL
    Neurosci Lett; 1985 May; 56(3):347-51. PubMed ID: 2410820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell loss and nuclear hypertrophy in topographical subdivisions of the nucleus basalis of Meynert in Alzheimer's disease.
    Iraizoz I; de Lacalle S; Gonzalo LM
    Neuroscience; 1991; 41(1):33-40. PubMed ID: 2057064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplantation of peripheral cholinergic neurons into Alzheimer model rat brain.
    Itakura T; Yokote H; Yukawa S; Nakai M; Komai N; Umemoto M
    Stereotact Funct Neurosurg; 1990; 54-55():368-72. PubMed ID: 2080352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
    Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease.
    Rasool CG; Svendsen CN; Selkoe DJ
    Ann Neurol; 1986 Oct; 20(4):482-8. PubMed ID: 3539000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease.
    Arendt T; Bigl V; Arendt A; Tennstedt A
    Acta Neuropathol; 1983; 61(2):101-8. PubMed ID: 6637393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The nucleus basalis of Meynert in 20 definite cases of Creutzfeldt-Jakob disease.
    Cartier L; Verdugo R; Vergara C; Galvez S
    J Neurol Neurosurg Psychiatry; 1989 Mar; 52(3):304-9. PubMed ID: 2647906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galanin-like immunoreactivity is present in human substantia innominata and in senile plaques in Alzheimer's disease.
    Kowall NW; Beal MF
    Neurosci Lett; 1989 Mar; 98(1):118-23. PubMed ID: 2469045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease.
    Rinne JO; Paljärvi L; Rinne UK
    J Neurol Sci; 1987 Jun; 79(1-2):67-76. PubMed ID: 3612173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropathological study on the nucleus basalis of Meynert in Pick's disease.
    Mizukami K; Kosaka K
    Acta Neuropathol; 1989; 78(1):52-6. PubMed ID: 2735190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A sex difference and no effect of ApoE type on the amount of cytoskeletal alterations in the nucleus basalis of Meynert in Alzheimer's disease.
    Salehi A; Gonzalez Martinez V; Swaab DF
    Neurobiol Aging; 1998; 19(6):505-10. PubMed ID: 10192208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
    Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
    Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlative decrease of large neurons in the neostriatum and basal nucleus of Meynert in Alzheimer's disease.
    Oyanagi K; Takahashi H; Wakabayashi K; Ikuta F
    Brain Res; 1989 Dec; 504(2):354-7. PubMed ID: 2598036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Morphometric study of the magnocellular basal forebrain system in patients with Alzheimer's disease].
    Kobayashi K; Fukutani Y; Nakamura I; Kawasaki Y; Suzuki M; Yamaguchi N; Nakanishi I
    No To Shinkei; 1990 Apr; 42(4):345-51. PubMed ID: 2390367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
    Whitehouse PJ
    Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
    [No Abstract]   [Full Text] [Related]  

  • 40. Calbindin-immunoreactive cholinergic neurones in the nucleus basalis of Meynert in Alzheimer-type dementia.
    Ichimiya Y; Emson PC; Mountjoy CQ; Lawson DE; Iizuka R
    Brain Res; 1989 Oct; 499(2):402-6. PubMed ID: 2804687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.